Idis has appointed Dr Suzanne Gagnon as its first chief medical officer.
Dr Gagnon will lead global medical affairs at Idis, which specialises in partnering with pharma firms to support patient access to medicines.
She was most recently chief medical officer at neuroscience company NuPathe, prior to which she spent ten years as chief medical officer at the clinical research organisation (CRO) Icon,
During her time at Icon, she gained senior level experience in medical, regulatory and clinical research operations, overseeing a staff of 400 professionals across 10 global locations.
“Suzanne brings senior leadership to our team and a unique blend of industry expertise to our customers that will help guide development and implementation of programmes that balance stakeholder requirements and effectively address the needs of patients,” said Natalie Douglas, CEO of Idis.
In addition to her industry experience, Dr Gagnon is adjunct professor, pharmaceutical product development at West Chester University, Pennsylvania.